UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039060
Receipt number R000044545
Scientific Title Study to elucidate the effect of humidity environment on the rough skin condition.
Date of disclosure of the study information 2020/01/06
Last modified on 2020/01/06 11:57:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of humidity environment on the rough skin condition.

Acronym

Study of humidity environment on the rough skin condition.

Scientific Title

Study to elucidate the effect of humidity environment on the rough skin condition.

Scientific Title:Acronym

Study of humidity environment on the rough skin condition.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the influence of humidity on the rough skin feature.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

water content, transepidermal water loss, surface texture, stratum corneum composition and sebum composition

Key secondary outcomes

sweat volume, sweat components, skin surface pH and skin surface temperature


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

We perform acetone ether and water treatment on the inner part of the forearm to create rough skin. Then, we create a few closed environments, then its inside is conditioning humidity for 3 hours.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy males and females

Key exclusion criteria

1.Subjects with skin troubles or diseases on their face, especially such as atopic dermatitis, or psoriasis, or severe acne.
2.Subjects who have severe suntan in their faces.
3.Subjects who performs outdoor sport periodically.
4.Subjects who attend the hospital (such as gastrointestinal disease, liver disease, kidney disease, cardiovascular heart disease, skin disease, or poor physical condition). And, panelists for less than one month after attend the hospital.
5.Subjects who have taken a spa treatment (such as chemical peeling, or laser therapy) in the inner forearm region.
6.Subjects who are participating or plan to participate in other intervention tests (cosmetics, foods) in the inner forearm region during the test period.
7.Subjects who have experienced skin abnormalities (obvious erythema, edema, papules, blisters, etc.) by the tape striping and/or acetone ether and water treatment.
8.Subjects deemed inappropriate to participate in this study by the principle investigator.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Junko
Middle name
Last name Ishikawa

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

321-3497

Address

2606 Akabane, Ichikai-Machi, Haga-Gun, TOCHIGI, 321-3497, JAPAN

TEL

0285-68-7888

Email

ishikawa.junko1@kao.com


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Taoka

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

321-3497

Address

2606 Akabane, Ichikai-Machi, Haga-Gun, TOCHIGI, 321-3497, JAPAN

TEL

0285-68-7888

Homepage URL


Email

taoka.hiroki@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 10 Month 31 Day

Date of IRB

2019 Year 10 Month 31 Day

Anticipated trial start date

2019 Year 12 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 06 Day

Last modified on

2020 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044545


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name